International Clinical Trial: STARFAST: Study of Traumatic Brain Injury (TBI)/ Concussions in Australian-Rules Footballers receiving AST-004

Geneva, June 30 -- International Clinical Trials Registry received information related to the study (ACTRN12625000657426) titled 'STARFAST: Study of Traumatic Brain Injury (TBI)/ Concussions in Australian-Rules Footballers receiving AST-004' on June 20.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Astrocyte Pharmaceuticals Pty Ltd

Condition: Concussion Concussion Neurological - Neurodegenerative diseases Injuries and Accidents - Other injuries and accidents

Intervention: AST-004 will be infused as Low Dose: 100 mg loading dose infused over 10 minutes followed by 80 mg/hr for 6 hours or High Dose: 130 mg loading dose infused over 10 minutes followed by 180 mg/h...